Mullennix Stephen

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 94% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mullennix Stephen's trades of Urogen Pharma Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
132.60
Quantity 10,091 -19.0%
Value US$1,272,344
Transaction date
Sale
Price
266.51
Quantity 24,758 +14.5%
Value US$202,804
Transaction date
Sale
Price
396.17
Quantity 57,424 -41.6%
Value US$1,962,690
Transaction date
Sale
Price
37.98
Quantity 608 -10.2%
Value US$23,092
Transaction date
Sale
Price
37.30
Quantity 2,804 -39.9%
Value US$104,589
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-04-28 2020-04-27
S Sale
10,091 -19.0%
132.60
US$1,272,344 		10,091 -19.0% 132.60 US$1,272,344
2020-02-18 2020-02-14
S Sale
24,758 +14.5%
266.51
US$202,804 		24,758 +14.5% 266.51 US$202,804
2020-01-28 2020-01-27
S Sale
57,424 -41.6%
396.17
US$1,962,690 		57,424 -41.6% 396.17 US$1,962,690
2019-05-16 2019-05-14
S Sale
608 -10.2%
37.98
US$23,092 		608 -10.2% 37.98 US$23,092
2019-03-07 2019-02-14
S Sale
2,804 -39.9%
37.30
US$104,589 		2,804 -39.9% 37.30 US$104,589